查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927725

全球基因檢測市場：依疾病類型、技術、最終用戶、國家及地區分類－產業分析、市場規模、佔有率及2025年至2032年未來預測

Hereditary Testing Market, Report Disease Type, By Technology, End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，基因檢測市場規模將達到 161.102 億美元，從 2025 年到 2032 年，年複合成長率將達到 14.01%。

由於遺傳疾病盛行率上升、意識提升以及檢測技術的進步，全球基因檢測市場正經歷顯著成長。基因檢測在遺傳風險評估中發揮關鍵作用，並廣泛應用於產前篩檢、癌症易感性檢測和攜帶者篩檢。次世代定序技術的應用以及基因檢測服務可近性的提高是推動已開發地區和新興地區市場成長的關鍵因素。

基因檢測市場動態

遺傳疾病呈上升趨勢

囊腫纖維化、鐮狀貧血症和各種遺傳性癌症等遺傳性疾病的日益普遍是推動基因檢測市場發展的主要因素，因為定期進行基因篩檢和監測對於有效的疾病管理、風險評估和患者諮詢至關重要。多基因panel檢測技術的進步顯著提高了診斷的準確性、效率和臨床效用，促進了其在常規實踐中的廣泛應用。醫護人員和患者對基因檢測在個人化醫療中作用的認知不斷提高，進一步推動了市場需求。例如，2024年11月，CeGaT GmbH推出了其改良的EXOME富集產品“ExomeXtra v6”，該產品擴展了對非編碼剪接區域和拷貝數變異（CNV）的分析範圍，從而能夠更精確地診斷包括腫瘤症候群在內的遺傳性疾病。此外，實驗室自動化、數位健康平台和遠端醫療領域的持續創新提高了檢測的可近性和周轉時間，為市場的持續成長和技術進步提供了支援。

基因檢測市場：細分分析

全球基因檢測市場按疾病類型、技術、最終用戶和地區進行細分。

根據疾病類型，市場可細分為囊腫纖維化、鐮狀貧血、血友病和其他遺傳性疾病。由於囊腫纖維化和鐮狀細胞貧血症的高發生率以及對早期診斷和治療日益成長的需求，這兩種疾病的檢測佔據了相當大的市場佔有率。現有篩檢計畫的廣泛應用以及人們對遺傳性疾病認知的提高也是推動市場成長的因素。此外，早期療育策略和新生兒篩檢計畫也促進了檢測率的提高。

依技術分類，市場可分為次世代定序(NGS)、聚合酵素鏈鎖反應(PCR)、微陣列和其他技術。次世代定序憑藉其在基因檢測中提供的高精度和高效率，在業界佔據主導地位。它能夠同時分析多個基因，從而縮短檢測週期並降低成本。臨床應用的不斷拓展和定序成本的持續下降，進一步推動了下一代定序技術的普及。

根據最終用戶，市場可細分為醫院、診斷檢查室、基因檢測中心和其他機構。其中，醫院和診斷檢查室佔據最大佔有率，能夠進行大規模檢測，並透過全面的基因服務來支援病患管理。多學科醫療團隊和先進的診斷基礎設施進一步提升了這些機構在遺傳疾病診斷和監測方面的作用。

基因檢測市場—區域分析

北美地區在基因檢測市場佔據領先地位，這主要得益於其先進的醫療基礎設施和較高的基因檢測普及率。該地區持續的研究活動和有利的報銷政策是推動市場成長的主要動力。歐洲緊隨其後，其強大的公共衛生體系和日益增強的遺傳疾病意識為其發展提供了支持。亞太地區預計將成為成長最快的地區，這主要歸功於醫療費用支出的增加、意識提升以及基因檢測技術的進步。拉丁美洲和中東及非洲國家預計將保持穩定成長，這得益於醫療保健服務的逐步改善和對基因檢測服務需求的不斷成長。

基因檢測市場—國家分析

美國憑藉龐大的檢測量、先進的診斷技術以及許多大型基因檢測公司，在基因檢測市場佔據主導地位。在歐洲，德國、英國和法國等國在完善的醫療保健體系的支持下，大力推動市場成長，這些體系鼓勵常規基因檢測。在亞洲，中國和印度正迅速崛起為成長最快的市場，這主要得益於其龐大的人口基數、日益增強的遺傳健康意識以及不斷完善的醫療基礎設施。這些因素使得基因檢測解決方案更加普及，推動了整個市場的需求。

目錄

第1章 基因檢測市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：基因檢測市場的主要趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章 基因檢測市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 基因檢測市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 基因檢測市場現狀

  • 基因檢測市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 依疾病類型分類的基因檢測市場

  • 概述
    • 細分市場佔有率分析：依疾病類型分類
    • 囊腫纖維化
    • 鐮狀細胞性貧血症
    • 血友病
    • 其他

第8章 按技術分類的基因檢測市場

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 次世代定序（NGS）
    • 聚合酵素鏈鎖反應（PCR）
    • 微陣列
    • 其他

第9章 依最終用戶分類的基因檢測市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院
    • 診斷檢查室
    • 基因檢測中心
    • 其他

第10章 各地區的基因檢測市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析—基因檢測產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Illumina
    • Thermo Fisher Scientific
    • Quest Diagnostics
    • Invitae Corporation
    • Agilent Technologies
    • Myriad Genetics
    • GeneDx
    • Fulgent Genetics
    • Archerdx
    • BGI Group
    • Others

第12章：分析師視角360度分析

簡介目錄
Product Code: ANV5962

The Hereditary Testing Market size was valued at US$16,110.20 Million in 2024, expanding at a CAGR of 14.01% from 2025 to 2032.

The global hereditary testing market is witnessing significant growth due to the rising prevalence of genetic disorders, increased public awareness, and advancements in testing technologies. Hereditary testing plays an essential role in assessing genetic risks and is widely utilized for prenatal screening, cancer susceptibility testing, and carrier screening. The integration of next-generation sequencing technologies and the expansion of access to genetic testing services are key factors driving market growth across both developed and emerging regions.

Hereditary Testing Market- Market Dynamics

Rising prevalence of genetic disorders

The rising prevalence of hereditary conditions such as cystic fibrosis, sickle cell disease, and various inherited cancers is a key driver of the hereditary testing market, as regular genetic screening and monitoring are essential for effective disease management, risk assessment, and patient counselling. Advancements in multi-gene panel testing have significantly improved diagnostic accuracy, efficiency, and clinical relevance, supporting broader adoption in routine care. Growing awareness among healthcare professionals and patients about the role of genetic testing in personalised medicine is further accelerating demand. For instance, in November 2024, CeGaT GmbH launched the enhanced ExomeXtra v6 exome enrichment product, offering expanded coverage of non-coding splice regions and copy number variations (CNVs) to enable more precise diagnostics for hereditary conditions, including tumour syndromes. Additionally, continuous innovations in laboratory automation, digital health platforms, and telemedicine are improving accessibility and turnaround times, reinforcing sustained market growth and technological advancement.

Hereditary Testing Market- Segmentation Analysis:

The Global Hereditary Testing Market is segmented based on Disease Type, Technology, End User, and Region.

Based on Disease Type, the market is segmented into Cystic Fibrosis, Sickle Cell Disease, Hemophilia, and Other Genetic Disorders. Cystic fibrosis and sickle cell disease testing account for significant shares due to their high prevalence and the increasing demand for early diagnosis and management. The availability of established screening programs and growing awareness of inherited disorders further support market growth. Additionally, early intervention strategies and newborn screening initiatives contribute to higher testing rates.

Based on Technology, the market is categorised into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Others. Next-generation sequencing dominates this segment, driven by advancements that offer high accuracy and efficiency in genetic testing. Its ability to analyse multiple genes simultaneously reduces turnaround time and cost per test. Expanding clinical applications and declining sequencing costs further strengthen NGS adoption.

Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Genetic Testing Centres, and Others. Hospitals and diagnostic laboratories hold the largest share, as they facilitate high volumes of testing and support patient management through comprehensive genetic services. The presence of multidisciplinary care teams and advanced diagnostic infrastructure enhances their role in genetic disease diagnosis and monitoring.

Hereditary Testing Market- Geographical Insights

North America leads the hereditary testing market, driven by its advanced healthcare infrastructure and high adoption rates of genetic testing. This region benefits from ongoing research initiatives and favourable reimbursement policies. Europe follows closely, supported by strong public health systems and increasing awareness of genetic disorders. The Asia-Pacific region is expected to experience the fastest growth, fueled by rising healthcare expenditures, increased public awareness, and developments in genetic testing technology. Countries in Latin America and the Middle East & Africa are displaying steady growth due to gradual improvements in healthcare access and growing demand for genetic testing services.

Hereditary Testing Market- Country Insights

The United States holds a dominant position in the hereditary testing market, primarily due to high testing volumes, advanced diagnostics, and the presence of leading genetic testing companies. In Europe, countries like Germany, the UK, and France significantly contribute to market growth, supported by well-established healthcare systems promoting regular genetic testing. In Asia, China and India are rapidly emerging as high-growth markets, driven by large populations, increasing awareness of genetic health issues, and expanding healthcare infrastructure. This landscape enhances the accessibility and availability of hereditary testing solutions, driving overall market demand.

Hereditary Testing Market- Competitive Landscape:

The hereditary testing market is moderately competitive, featuring key players such as Illumina, Thermo Fisher Scientific, Quest Diagnostics, Invitae Corporation, Agilent Technologies, Myriad Genetics, GeneDx, Fulgent Genetics, ArcherDX, and BGI Group. These companies focus on assay innovation, automation, and expanding their test portfolios to meet growing healthcare demands. Significant investments in next-generation sequencing technologies, streamlined workflows, and integrated solutions are enhancing accuracy and efficiency. Strategic partnerships and geographic expansion are key strategies that enable participants to strengthen their market positions in response to the increasing demand for hereditary testing services, for instance, February 2025: Fulgent Genetics, Inc. partnered with Foundation Medicine, Inc. to introduce two hereditary germline tests FoundationOne Germline and FoundationOne Germline More in the U.S., leveraging Fulgent's advanced technology platform to enhance comprehensive genetic testing capabilities.

Recent Developments:

In November 2024, CeGaT GmbH launched version 6 (v6) of its proprietary ExomeXtra exome enrichment product, enhancing coverage of non-coding splice regions and copy number variations (CNVs). This upgrade supports improved diagnostic accuracy, particularly for hereditary tumour syndromes, by enabling the detection of a broader spectrum of genetic alterations, including rare and complex variants that were previously challenging to identify.

In October 2023 a rural hospital system in North Carolina, in collaboration with Invitae, implemented universal hereditary testing for all breast cancer patients. The initiative achieved a 91.4% testing uptake and identified pathogenic germline variants in 13% of tested patients, leading to changes in clinical management for nearly 70% of cases. This program highlights the effectiveness of integrating hereditary testing into diverse healthcare settings, enhancing patient outcomes while optimising the use of healthcare resources.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEREDITARY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Invitae Corporation
  • Agilent Technologies
  • Myriad Genetics
  • GeneDx
  • Fulgent Genetics
  • Archerdx
  • BGI Group
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cystic Fibrosis
  • Sickle Cell Disease
  • Hemophilia
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Genetic Testing Centers
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hereditary Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hereditary Testing Market Snippet by Disease Type
    • 2.1.2. Hereditary Testing Market Snippet by Technology
    • 2.1.3. Hereditary Testing Market Snippet by End User
    • 2.1.4. Hereditary Testing Market Snippet by Country
    • 2.1.5. Hereditary Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Hereditary Testing Key Market Trends

  • 3.1. Hereditary Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hereditary Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hereditary Testing Market Opportunities
  • 3.4. Hereditary Testing Market Future Trends

4. Hereditary Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hereditary Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hereditary Testing Market Landscape

  • 6.1. Hereditary Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hereditary Testing Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024&2032 (%)
    • 7.1.2. Cystic Fibrosis
    • 7.1.3. Sickle Cell Disease
    • 7.1.4. Hemophilia
    • 7.1.5. Others

8. Hereditary Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Microarray
    • 8.1.5. Others

9. Hereditary Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Genetic Testing Centers
    • 9.1.5. Others

10. Hereditary Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hereditary Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hereditary Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hereditary Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Hereditary Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Hereditary Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Hereditary Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Illumina
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. Quest Diagnostics
    • 11.2.4. Invitae Corporation
    • 11.2.5. Agilent Technologies
    • 11.2.6. Myriad Genetics
    • 11.2.7. GeneDx
    • 11.2.8. Fulgent Genetics
    • 11.2.9. Archerdx
    • 11.2.10. BGI Group
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us